SUBSCRIBE: Print / eNewsletter
In a good percentage of patients who have oligometastatic disease confined to a single organ—usually the liver—complete metastasectomy can result in cure. However, once the decision to pursue surgery is made, there remain a number of issues that must be addressed in order to ensure the best possible outcome.
In the current issue of ONCOLOGY
Drs. Bendell and Ryan have provided
a valuable review of anal
cancer. They describe the dramatic
effect of multimodality therapy on
the quality of life and survival of
anal cancer patients. Currently, the
majority of patients enjoy long-term
survival without requiring major surgery
or a stoma. At Memorial Sloan-
Kettering Cancer Center, we base
treatment recommendations on stage
at presentation and the presence of
comorbid disease.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
